755 related articles for article (PubMed ID: 32441559)
21. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
22. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.
Koopen AM; Groen AK; Nieuwdorp M
Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota: a target for intervention in obesity.
Sehgal K; Khanna S
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.
Solas M; Milagro FI; Ramírez MJ; Martínez JA
Curr Opin Pharmacol; 2017 Dec; 37():87-92. PubMed ID: 29107872
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization.
de la Cuesta-Zuluaga J; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Sci Rep; 2018 Jul; 8(1):11356. PubMed ID: 30054529
[TBL] [Abstract][Full Text] [Related]
26. Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity.
Rovella V; Rodia G; Di Daniele F; Cardillo C; Campia U; Noce A; Candi E; Della-Morte D; Tesauro M
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33668627
[TBL] [Abstract][Full Text] [Related]
27. Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
Brahe LK; Astrup A; Larsen LH
Adv Nutr; 2016 Jan; 7(1):90-101. PubMed ID: 26773017
[TBL] [Abstract][Full Text] [Related]
28. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
29. Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids.
Pekmez CT; Dragsted LO; Brahe LK
Clin Nutr; 2019 Apr; 38(2):615-630. PubMed ID: 29496274
[TBL] [Abstract][Full Text] [Related]
30. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
31. Microbiome response to diet: focus on obesity and related diseases.
Delzenne NM; Rodriguez J; Olivares M; Neyrinck AM
Rev Endocr Metab Disord; 2020 Sep; 21(3):369-380. PubMed ID: 32691288
[TBL] [Abstract][Full Text] [Related]
32. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
[TBL] [Abstract][Full Text] [Related]
33. The microbiota-gut-brain axis in obesity.
Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
[TBL] [Abstract][Full Text] [Related]
34. Peripheral and central regulation of insulin by the intestine and microbiome.
Schertzer JD; Lam TKT
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E234-E239. PubMed ID: 33308015
[TBL] [Abstract][Full Text] [Related]
35. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
Petra AI; Panagiotidou S; Hatziagelaki E; Stewart JM; Conti P; Theoharides TC
Clin Ther; 2015 May; 37(5):984-95. PubMed ID: 26046241
[TBL] [Abstract][Full Text] [Related]
36. The microbiota-immune axis as a central mediator of gut-brain communication.
Fung TC
Neurobiol Dis; 2020 Mar; 136():104714. PubMed ID: 31846737
[TBL] [Abstract][Full Text] [Related]
37. Obesity and gut-microbiota-brain axis: A narrative review.
Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S
J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277
[TBL] [Abstract][Full Text] [Related]
38. The mutual interplay of gut microbiota, diet and human disease.
Illiano P; Brambilla R; Parolini C
FEBS J; 2020 Mar; 287(5):833-855. PubMed ID: 31955527
[TBL] [Abstract][Full Text] [Related]
39. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota and obesity.
Gérard P
Cell Mol Life Sci; 2016 Jan; 73(1):147-62. PubMed ID: 26459447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
